Genmab — November 2014
-
Det går5 da den rigtige vej for dem. Nu mangler de bare at lukke 59%
-
0,59%
-
Nu ødelægger Putin det vel igen? http://ekstrabladet.dk/nyheder/krigogkatastrofer/article5290145.ece
-
http://www.haematologica.org/content/haematol/early/2014/10/20/haematol.2014.107011.full.pdf Artiklen Winkel omtalte på PIs Q&A
-
Hej Solsen. Tak for link. Det ser ud til at der ikke er store synergier i at bruge både inhibitor og CD20 mAbs. Det er mere 1+1=2 og hvis man ikke passer på 1,5. CDC mekanismen bliver ikke påvirket af inhibitor og derfor er Ofatumumab en favorit til kombi behandling
-
Det kører bare derudad
-
og igen, hver gang de starter nye forsøg tænker jeg (de kender allerede data fra BTD studiet).
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind